Pharming (PHAR) Non Operating Income (2021 - 2026)
Pharming (PHAR) posted Non Operating Income of $543000.0 for Q1 2026, up 103.99% on a QoQ basis from -$13.6 million in Q4 2025, and up 112.08% year-over-year from $256032.1 in Q1 2025.
Pharming (PHAR) Non Operating Income (2021 - 2026) Analysis & Trends
Pharming's Non Operating Income history runs 6 years deep, the most recent figure standing at $543000.0 for Q1 2026.
- Quarterly Non Operating Income rose 112.08% year-over-year to $543000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$19.9 million (down 663.19% YoY) and the FY2025 annual result came in at -$13.6 million, down 820.91% from the prior year.
- Non Operating Income was $543000.0 for Q1 2026 at Pharming, up from -$13.6 million in the prior quarter.
- Across five years, Non Operating Income topped out at $3.6 million in Q2 2024 and bottomed at -$13.6 million in Q4 2025.
- A 5-year average of -$2.3 million and a median of -$964500.0 in 2024 frame the typical range for Non Operating Income.
- Annual changes were most pronounced in 2024 — Non Operating Income jumped 180.43% — and 2025, when it sank 3073.36%.
- Pharming's Non Operating Income stood at $1.8 million in 2022, then sank by 452.0% to -$6.3 million in 2023, then soared by 107.23% to $458000.0 in 2024, then sank by 3073.36% to -$13.6 million in 2025, then jumped by 103.99% to $543000.0 in 2026.
- Business Quant data shows PHAR's Non Operating Income at $543000.0 in Q1 2026, -$13.6 million in Q4 2025, and $1.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 444,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -8.59 Mn |
| 10 | Pharming | 8.69 Bn | 8.64 Bn | 65.80 Mn | 543,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 543,000.00 |
| Dec 31, 2025 | -13.62 Mn |
| Sep 30, 2025 | 1.72 Mn |
| Jun 30, 2025 | -8.52 Mn |
| Mar 31, 2025 | -4.49 Mn |
| Dec 31, 2024 | 458,000.00 |
| Sep 30, 2024 | -2.15 Mn |
| Jun 30, 2024 | 3.58 Mn |
| Mar 31, 2024 | 223,000.00 |
| Dec 31, 2023 | -6.34 Mn |
| Sep 30, 2023 | 1.88 Mn |
| Jun 30, 2023 | -4.46 Mn |
| Mar 31, 2023 | -2.67 Mn |
| Mar 31, 2022 | 1.80 Mn |
| Mar 31, 2021 | 6.60 Mn |